EMD-20260
HIV Env 16055 NFL TD 2CC+ in complex with antibody 1C2 fragment antigen binding
EMD-20260
Single-particle3.94 Å
Deposition: 31/05/2019Map released: 20/11/2019
Last modified: 13/11/2024
Sample Organism:
Human immunodeficiency virus 1,
Oryctolagus cuniculus
Sample: HIV Env 16055 NFL TD 2CC+ in complex with antibody 1C2 fragment antigen binding
Fitted models: 6p65
Deposition Authors: Ozorowski G, Torres JL
Sample: HIV Env 16055 NFL TD 2CC+ in complex with antibody 1C2 fragment antigen binding
Fitted models: 6p65
Deposition Authors: Ozorowski G, Torres JL
Vaccination with Glycan-Modified HIV NFL Envelope Trimer-Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of Vulnerability.
Dubrovskaya V,
Tran K,
Ozorowski G,
Guenaga J,
Wilson R,
Bale S,
Cottrell CA ,
Turner HL,
Seabright G,
O'Dell S,
Torres JL ,
Yang L,
Feng Y,
Leaman DP,
Vazquez Bernat N,
Liban T,
Louder M,
McKee K,
Bailer RT,
Movsesyan A,
Doria-Rose NA,
Pancera M,
Karlsson Hedestam GB,
Zwick MB,
Crispin M ,
Mascola JR,
Ward AB,
Wyatt RT
(2019) Immunity , 51 , 915 - 929.e7
,
Turner HL,
Seabright G,
O'Dell S,
Torres JL ,
Yang L,
Feng Y,
Leaman DP,
Vazquez Bernat N,
Liban T,
Louder M,
McKee K,
Bailer RT,
Movsesyan A,
Doria-Rose NA,
Pancera M,
Karlsson Hedestam GB,
Zwick MB,
Crispin M ,
Mascola JR,
Ward AB,
Wyatt RT
(2019) Immunity , 51 , 915 - 929.e7
Grant Support:
- National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID): UM AI100663 (United States)
- Bill & Melinda Gates Foundation: OPP1115782 (United States)
- Bill & Melinda Gates Foundation: OPP1084519 (United States)
- National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID): AI136621 (United States)